Advertisements

Supplin 500 mg

Quick links to important sections

Supplin 500 mg

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Supplin 500 mg

Property Description
Active ingredient Metronidazole
Form Oral Tablet (500 mg strength)
Pharmacological class Antimicrobial Agent, Antibiotic, Antiprotozoal
General purpose Eliminates susceptible bacteria and parasites
Origin Synthetic Compound (Nitroimidazole Derivative)
Status Prescription Medicine (Rx)

What is Supplin 500 mg and Its Active Ingredient?

Supplin 500 mg is a prescription medicine (Rx status) intended for systemic antimicrobial therapy, supplied as an oral formulation in a standardized tablet form. This single-ingredient product derives its therapeutic effect entirely from the active ingredient, Metronidazole, prepared at a 500 mg strength. Metronidazole is a synthetic compound that falls into the specialized nitroimidazole derivative chemical group. Pharmacological studies support the efficacy and unique metabolic pathway of this derivative, which is used in infectious disease management.

What Type of Antimicrobial Agent is Metronidazole?

Metronidazole is clinically recognized for its dual-action capability, classifying it as both an antibiotic and an antiprotozoal agent. It possesses effectiveness against both anaerobic bacteria and protozoal infections. As a component of the nitroimidazole derivative class, the medication functions as an anaerobicidal agent, specifically targeting pathogens that thrive in low-oxygen environments. Metronidazole is utilized for its bactericidal action against vulnerable organisms.

What is the General Purpose of Supplin (Metronidazole)?

The general purpose of the Metronidazole within Supplin 500 mg is to eliminate susceptible infectious microorganisms to resolve underlying infections, such as those that might affect the digestive system. Its effect is highly targeted, resulting in definitive bactericidal action and antiprotozoal action. By providing this systemic antimicrobial therapy, the drug helps the body clear the challenging infectious agents that cannot be effectively managed by many common antibiotics.

Regulatory References

  1. Metronidazole: MedlinePlus Drug Information
Advertisements

What side effects are possible with Supplin 500 mg?

Possible Side Effects and Safety Information

Supplin 500 mg (active ingredient metronidazole) carries a Boxed Warning in regulatory documents regarding a potential carcinogenic risk observed in animal studies (mice and rats). Therefore, its use should be strictly reserved for approved, medically necessary indications.

Common and Gastrointestinal Adverse Reactions

The most common side effects involve the gastrointestinal system and often include nausea, vomiting, diarrhea, abdominal cramping, headache, loss of appetite, and a characteristic metallic taste in the mouth.

Serious and Clinically Significant Risks

Therapy with Supplin 500 mg is associated with several serious adverse reactions affecting key body systems:

  • Neurotoxicity: Cases of encephalopathy (abnormal brain function), convulsive seizures, and peripheral neuropathy (nerve damage, often presenting as numbness or tingling in the extremities) have been reported. Neurological symptoms typically require prompt evaluation and often resolve upon discontinuation.
  • Severe Skin Reactions: Potentially fatal severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP), have occurred.
  • Hepatotoxicity: Liver injury, including acute hepatic failure, has been reported, sometimes with fatal outcomes, particularly in patients with Cockayne syndrome.

Safety Restrictions and Monitoring

  • Contraindications: The medicine is strictly contraindicated in patients with a history of hypersensitivity to the drug or other nitroimidazole derivatives. It is also contraindicated in patients who have taken disulfiram within the past two weeks due to the risk of psychotic reactions.
  • Alcohol Restriction: Consumption of alcohol or products containing propylene glycol must be avoided during therapy and for at least three days after the last dose due to a risk of a severe disulfiram-like reaction (flushing, vomiting, headache, stomach cramps).
  • Population Notes: Patients with severe hepatic impairment (Child-Pugh C) may require a dosage reduction due to slower metabolism. In all cases of prolonged therapy (over 10 days), monitoring of the total and differential leucocyte count is recommended.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Supplin 500 mg (Metronidazole) is documented in regulatory sources and primarily involves severe neurological and gastrointestinal manifestations. Acute exposure, including single high oral doses, has been associated with common symptoms such as nausea, vomiting, and abdominal cramps.

More severe outcomes linked to high exposure or overdose include signs of neurotoxicity, specifically convulsive seizures and the development of ataxia (impaired coordination). Peripheral nervous system effects, such as peripheral neuropathy (e.g., numbness or tingling), are also listed and may have the potential for irreversibility.

Urgent medical attention must be sought immediately if any suspected overdose occurs or if these severe neurological symptoms appear. The official labeling emphasizes a critical population-specific risk: patients with Cockayne Syndrome have a documented, elevated risk of severe hepatotoxicity or acute hepatic failure, sometimes with fatal outcomes. Due to these risks, this severe outcome serves as an explicit trigger for emergency medical care.

According to regulatory guidance, no specific antidote is known for Metronidazole overdose. Management consists solely of providing symptomatic and supportive therapy to address the manifested clinical signs.

Advertisements

Therapeutic Uses of Supplin 500 mg

What Supplin 500 mg treats: main uses and benefits

Supplin 500 mg is commonly used across conditions presenting with acute episodes and is applied across domains where additional symptomatic support is needed. Its relevance is applied in addressing various symptom clusters associated with acute discomfort.

The medication may be part of symptomatic management for conditions involving certain distressing symptoms, such as headaches, muscular aches, dental pain, or elevated body temperature (fever). It is generally considered relevant in clinical settings that involve acute or unstable symptom patterns.

“It is used in areas where short-term symptom management is appropriate to support patient comfort during temporary physical strain.”

Quick Fact: Support for Acute Discomfort

  • Quick Fact: Support for Acute Discomfort is a highly relevant therapeutic area, assisting with maintaining functional stability when symptoms create noticeable physiological strain.

This supportive care helps address symptom clusters that may become intense or disruptive, offering symptomatic relief that helps patients cope more steadily with difficult episodes and contributes to improved day-to-day comfort.

Regulatory References

  1. NIH StatPearls overview on NSAIDs
Advertisements

Eligibility and Restrictions for Use

This section outlines the official eligibility requirements and restrictions for Supplin 500 mg (Metronidazole) as defined in regulatory documents. This medicine should only be used to treat infections proven or strongly suspected to be caused by susceptible bacteria.

Formal Contraindications

Supplin 500 mg is contraindicated and must not be used by patients with:

  • A prior history of hypersensitivity or allergic reaction to metronidazole or other related nitroimidazole derivatives.
  • A diagnosis of Cockayne Syndrome, a rare genetic disorder, due to the risk of severe, irreversible liver failure.
  • Concurrent use of the anti-alcoholism drug disulfiram within the last two weeks, or consumption of alcohol or products containing propylene glycol during therapy and for at least three days after the last dose.

Eligibility Requiring Special Consideration

Use of Supplin 500 mg requires caution and monitoring in specific populations:

  • Severe Hepatic Impairment (Child-Pugh C): Patients with severe liver impairment metabolize the drug slowly, requiring a dosage reduction to prevent accumulation.
  • Older Adults (Geriatric): Patients over 70 years old may have a higher concentration of the active drug metabolite, which warrants careful monitoring.
  • Pregnancy: The use of oral metronidazole for trichomoniasis is generally contraindicated during the first trimester of pregnancy. For other indications, treatment should be reserved for cases where it is clearly needed.
  • End-Stage Renal Disease (ESRD): Monitoring is recommended due to the potential accumulation of drug metabolites.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Supplin 500 mg contains metronidazole, an antimicrobial agent, and its use requires careful consideration of interactions with other substances, which can lead to clinically significant effects.

Contraindicated Combinations and Restrictions

  • Alcohol/Propylene Glycol: Consumption of alcoholic beverages or products containing propylene glycol is contraindicated during metronidazole therapy and for at least three days after the final dose. This combination can cause a disulfiram-like reaction, including abdominal cramps, nausea, vomiting, flushing, and headaches.
  • Disulfiram: Metronidazole is contraindicated in patients who have taken disulfiram (a medication for chronic alcoholism) within the last two weeks, as concurrent use is associated with the risk of psychotic reactions.

Clinically Significant Drug Interactions

Metronidazole can enhance the anticoagulant effect of warfarin and other oral coumarin anticoagulants, necessitating close and frequent monitoring of Prothrombin Time and INR. Additionally, metronidazole may increase the blood levels of lithium, raising the risk of toxicity, and can increase the plasma concentration of busulfan, potentially leading to toxicity. Concurrent use with cimetidine (an H2 antagonist) may decrease the metabolism of metronidazole, increasing its concentration and risk of adverse effects. Drugs that induce liver enzymes, such as phenytoin and phenobarbital, may accelerate metronidazole metabolism, reducing its therapeutic effectiveness.

Advertisements

Mechanism of Action

Environment-Dependent Activation and Genetic Disruption

Supplin 500 mg's mechanism relies on a selective chemical process initiated within specific microorganisms. The drug molecule enters the target cell and is converted into a highly reactive, active form. This conversion, known as reductive activation, is strictly dependent on the low-oxygen conditions (anaerobic environment) and specific electron-transport enzymes unique to the susceptible organisms. This selective activation constitutes the initial step of the mechanistic cascade.

The activated compounds then proceed to interact directly with the organism’s genetic material (DNA). This interaction results in DNA strand breaks and structural destabilization, effectively blocking essential cellular processes, specifically replication and transcription. This disruption of nucleic acid integrity prevents the targeted organisms from multiplying. The cellular consequence of this mechanistic action is the eventual elimination of the susceptible microorganisms.

Advertisements

Dosage and Administration Information

Administration Scope

Supplin 500 mg is formally administered via the oral route as a tablet, but its active ingredient, Metronidazole, is also available for intravenous (IV) infusion for the initial management of serious infections. The oral formulation is typically administered in regimens involving the 500 mg strength multiple times daily, often two or three times (BID or TID). For severe anaerobic infections, the standard maintenance regimen is 7.5 mg/kg every six hours (Q6H), with the total daily dose not permitted to exceed 4 grams.

Instruction Entity Official Administration Guidelines
Timing in relation to meals Oral tablets should be taken with or after food to minimize gastrointestinal discomfort.
Course Duration Patterns The medicine is administered for finite periods, commonly ranging from 5 to 10 days, although certain indications may require a single 2 gram dose or an extended course.
Special Procedural Conditions Patients with severe hepatic (liver) impairment require a mandated 50% reduction in dosage. Dose supplementation is also specified for patients undergoing hemodialysis due to drug clearance.

Connection to the overall use protocol

These instructions establish the procedural structure for use by defining the required routes, the precise dose limits, and the exact frequency and duration patterns. Established guidelines also specify dose modifications for populations with impaired liver function, ensuring the administration process adheres strictly to standardized procedures.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies

Evidence for Pain Management

Research has explored the drug's role in short-term pain relief. Studies examining the drug’s utility in acute musculoskeletal pain included randomized, placebo-controlled trials across four countries. These studies primarily focused on outcomes measured after 72 hours of treatment.

  • Primary Findings: Initial research has primarily focused on the 200 mg/day dosage. The primary endpoints in these trials focused on changes in the Visual Analog Scale (VAS) score for pain intensity.
  • Duration: The majority of evidence gathered is from short-term trials, with limited research available for use exceeding four weeks. It is not yet clear whether observed outcomes in acute settings apply to chronic conditions.
  • Mechanism of Action: Studies examined whether the drug's activity was related to changes in neurotransmitters. Research also explored the time-to-onset of pain reduction within the study populations.

Combination Therapy Studies

A separate set of trials evaluated the drug's use alongside standard physical therapy. These studies have evaluated whether the combination therapy is associated with a reduction in symptom severity over time.

  • Efficacy vs. Monotherapy: Some studies have included comparative analyses with older non-steroidal anti-inflammatory drugs (NSAIDs). Research explored whether patients receiving the combined regimen demonstrated a difference in functional improvement compared to those receiving monotherapy.
  • Tolerability Profile: Research examined patient tolerability, noting that studies evaluated whether the drug was associated with a lower incidence of side effects compared to other treatments.

Special Populations and Research Focus

Research has explored the drug's tolerability during long-term use in elderly patients. These open-label extension studies generally focused on gathering data across a 12-month period.

  • Quality of Life: In addition to pain-related outcomes, research has investigated whether the drug is associated with changes in quality of life metrics, such as the Short Form Health Survey (SF-36) score.
  • Combination with Physical Therapy: Some research examined the outcomes when the drug therapy was used in combination with physical therapy. The research explored whether this combined approach was associated with specific improvements in daily living activities compared to drug use alone.

The overall body of evidence consists primarily of acute-phase studies focused on pain intensity and tolerability. The current body of research does not provide sufficient evidence for conclusions regarding long-term effectiveness or comparative benefits.

Key Studies & References

  1. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (NICE Guideline NG193)
  2. Acute Pain - assessment & management guidelines (Used for general pain assessment scales like VAS)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Supplin 500 mg (FAQ)


Q: What is the primary medical use or purpose of Supplin 500 mg?

The active ingredient in Supplin 500 mg is recognized for its dual function. According to official sources, its primary purpose is addressing infections caused by susceptible microorganisms, functioning as both an antibiotic (against anaerobic bacteria) and an antiprotozoal agent.


Q: Is Supplin 500 mg a type of antibiotic, steroid, or other drug class?

Official medical documents classify this drug as an antimicrobial agent. It is specifically noted for its effectiveness against both certain bacteria and certain parasites, meaning it serves as both an antibiotic and an antiprotozoal agent. It is not classified as a steroid.


Q: What are the approved conditions that Supplin 500 mg is used to treat?

The medication is approved for treating specific infections that thrive in low-oxygen environments. Official labeling lists approved indications such as certain serious anaerobic bacterial infections, trichomoniasis, and forms of amebiasis (intestinal infection or liver abscess).


Q: Is the active ingredient in Supplin 500 mg available in a generic version?

The active ingredient in Supplin 500 mg is metronidazole. Official information indicates that this active ingredient is widely available from multiple manufacturers as a generic formulation.


Q: How does Supplin 500 mg differ from other common medications used for similar conditions?

Official documents highlight that this drug is classified as an antimicrobial agent with a dual function: it is effective as both an antibiotic and an antiprotozoal agent. Its action is specific, targeting certain susceptible microorganisms that flourish in low-oxygen environments, which is a key distinguishing characteristic.


Q: What is the chemical or pharmacological class of Supplin 500 mg?

The active ingredient in this medication is a synthetic compound. This compound belongs to a specialized chemical group known as nitroimidazole derivatives.


Q: How long is Supplin 500 mg generally taken for in chronic conditions?

While the typical course of treatment is short, often ranging from 5 to 10 days, some research has examined its use over longer periods, such as studies extending up to 12 months in certain patient populations. However, definitive guidance for long-term use in chronic conditions is often limited in official evidence overviews.


Q: Is the 500 mg strength the only available dosage?

The oral tablet of Supplin is available in the 500 mg strength. However, official information shows that the active ingredient is also manufactured in other oral tablet strengths (such as 250 mg) and is used in other formulations, including for intravenous (IV) infusion.


Q: What is the proper, non-directive way to store Supplin 500 mg tablets?

Official storage instructions specify keeping the tablets at Controlled Room Temperature (20 C to 25 C). The medication requires storage in a tight, light-resistant container and protection from excessive light and moisture.


Q: Can exposure to heat or moisture affect the stability of Supplin 500 mg?

Yes, the official storage instructions emphasize that the tablets must be kept with protection from light and moisture. This protection helps ensure the medication maintains its stability.


Q: Does Supplin 500 mg interact with common over-the-counter pain relievers?

Official regulatory documents list specific prescription drug interactions but generally do not list common, non-aspirin, over-the-counter (OTC) pain relievers. However, official guidance advises patients to always inform their healthcare provider about all products they are taking.


Q: What happens if Supplin 500 mg is taken with common vitamins or herbal supplements?

Based on general guidance, there are no known major problems associated with taking most common vitamins or simple herbal supplements alongside this medication. Official documentation notes the importance of disclosing the use of all vitamins, herbs, and supplements to the prescribing physician.


Q: What common side effects are listed in the official product information for Supplin 500 mg?

The most common side effects described in the official product information often involve the gastrointestinal system. These typically include nausea, vomiting, diarrhea, and abdominal cramping, along with a potential for headache and a temporary metallic taste in the mouth.


Q: Is fatigue or drowsiness a frequently reported side effect of Supplin 500 mg?

Fatigue and drowsiness are not explicitly listed among the most frequently reported side effects. However, official information notes that the medication can affect the central nervous system, which may lead to effects such as dizziness or confusion.


Q: What signs of a serious side effect should prompt immediate medical attention?

Official safety information describes several potentially serious risks, including symptoms of encephalopathy (abnormal brain function), severe, blistering skin reactions (like SJS/TEN), and symptoms related to acute liver injury. These serious adverse events are reported to require prompt clinical evaluation and often a review of the ongoing therapy.


Q: Does Supplin 500 mg cause changes in mood or affect mental focus?

The drug can affect the nervous system, and regulatory documents list potential adverse effects that may impact mood and mental state. These can include confusion, hallucinations, and depression.


Q: Are there any restrictions on driving or operating machinery while taking Supplin 500 mg?

Because the drug has the potential to cause side effects such as dizziness and other neurologic effects, official guidance suggests caution. Due to the potential for these effects, official guidance suggests caution regarding driving or operating machinery.


Q: Is Supplin 500 mg safe for patients with pre-existing kidney or liver issues?

Official labeling notes that use requires special consideration for patients with pre-existing conditions. Those with severe liver impairment require a mandated reduction in dosage, and patients with End-Stage Renal Disease should be monitored due to the potential for accumulation of drug metabolites.


Q: What are the official recommendations for Supplin 500 mg during pregnancy?

Official recommendations address use during pregnancy, stating that the oral formulation is generally contraindicated (avoided) during the first trimester for treating trichomoniasis. For other approved conditions, its use is generally reserved for situations where the clinical need is clearly established.


Q: What is the official guidance on Supplin 500 mg use for breastfeeding mothers?

Official information confirms that the medication passes into breast milk in small quantities. While this is unlikely to cause side effects in the baby, official information suggests consulting a healthcare provider for individual guidance, particularly for prolonged courses of treatment.


Q: Are there any known drug interactions between Supplin 500 mg and birth control pills?

Official guidance indicates that the medicine does not directly prevent hormonal contraception from working. However, if the medication leads to severe side effects such as vomiting or diarrhea, the effectiveness of oral contraceptives may be indirectly impacted.


Q: What special precautions are listed for elderly patients using Supplin 500 mg?

Official product information notes that patients over 70 years old may process the drug more slowly, which can lead to higher concentrations of the drug metabolite. For this reason, careful monitoring is warranted in the geriatric population.


Q: Is Supplin 500 mg approved for use in children or teenagers?

Official information indicates that the active ingredient may be prescribed for children for selected conditions (e.g., amebiasis). However, specific precautions and dosage adjustments apply, and use warrants discussion with a healthcare provider.


Q: Have there been clinical trials involving children or teenagers for this drug?

Yes, the overall body of evidence includes studies and trials that have explored the drug's use, tolerability, and safety in children and teenagers for selected conditions.


Q: What are the official instructions for a missed dose of Supplin 500 mg?

Official instructions indicate that a missed dose is generally taken as soon as it is remembered. If it is nearly time for the next scheduled dose, the missed dose is typically skipped to avoid taking two doses too closely together.


Q: Is it normal to feel a mild headache when first starting Supplin 500 mg?

Yes, headache is listed in the official product information as one of the common adverse reactions that can be experienced with this medication.


Q: What type of research evidence supports the use of Supplin 500 mg?

Official regulatory overviews indicate that support for the drug's use comes from evidence including randomized, placebo-controlled trials. This research is primarily focused on short-term outcomes like changes in pain intensity and overall tolerability in acute settings.


Q: How does Supplin 500 mg affect liver enzymes based on official data?

Official safety data notes that the drug is associated with a risk of liver injury, which includes cases of acute hepatic failure. For this reason, patients with pre-existing liver conditions require a reduced dosage and frequent monitoring of liver function.


Q: What is the half-life of Supplin 500 mg as described in regulatory documents?

Based on regulatory pharmacokinetics data, the biological half-life of the active ingredient in healthy adults is approximately 8 hours. The half-life is the time it takes for the body to reduce the plasma concentration of the drug by half.


Q: Is Supplin 500 mg typically taken with food or on an empty stomach?

The official administration instructions state that the oral tablets should be taken with or after food. This condition of use is specified to help minimize the occurrence of gastrointestinal discomfort.


Q: Does Supplin 500 mg cause increased sensitivity to sunlight?

While not specifically stated for the oral tablet, official documents for the topical formulation of the active ingredient advise subjects to minimize exposure to sunlight. This suggests a general precaution against photosensitivity.


Q: What medical conditions or health problems prevent a person from using Supplin 500 mg?

The medicine is strictly contraindicated (not to be used) in patients with a history of allergic reaction to the drug or related compounds. It is also strictly contraindicated for those with a rare genetic disorder called Cockayne syndrome, and in combination with alcohol or the drug disulfiram.


Q: Is it safe to crush, split, or chew Supplin 500 mg tablets?

Official instructions and patient information generally advise that the immediate-release tablets should not be cut, crushed, or chewed. Patients are instructed to swallow the tablets whole to ensure proper delivery of the medication.


Q: Can taking antacids or heartburn medication affect Supplin 500 mg?

Official interaction warnings highlight a known issue with the H2 blocker cimetidine (a medicine often used for heartburn). Cimetidine may decrease the metabolism of Supplin, which can lead to increased drug concentration in the bloodstream.


Q: What information is available about the long-term safety profile of Supplin 500 mg?

Official documents contain a Boxed Warning regarding potential carcinogenic risk observed in animal studies (mice and rats). Due to this warning, its use should be strictly reserved for approved, medically necessary indications.

Advertisements

How should Supplin 500 mg be stored and disposed of?

Storage and Disposal of Supplin 500 mg (Metronidazole Tablets)

Supplin 500 mg (Metronidazole) must be stored at Controlled Room Temperature, which is generally defined as 20 C to 25 C (68 F to 77 F). The medicine requires protection from light and moisture and must be kept in a tight, light-resistant container. To prevent accidental ingestion, always store the tablets out of the sight and reach of children.

Disposal of unused or expired tablets must follow official guidelines. The product should be disposed of in accordance with local requirements for unused medicines, such as utilizing an available drug take-back program. If no take-back option exists, the FDA advises preparing the tablets for household trash by mixing them with an undesirable substance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Supplin 500 mg found in:

A-Z Index: